Sadler Natalie C, Nandhikonda Premchendar, Webb-Robertson Bobbie-Jo, Ansong Charles, Anderson Lindsey N, Smith Jordan N, Corley Richard A, Wright Aaron T
Biological Sciences Division (N.C.S., P.N., C.A., L.N.A., J.N.S., R.A.C., A.T.W.) and Computational and Statistical Analytics Division (B.J.W.R.), Pacific Northwest National Laboratory, Richland, Washington.
Biological Sciences Division (N.C.S., P.N., C.A., L.N.A., J.N.S., R.A.C., A.T.W.) and Computational and Statistical Analytics Division (B.J.W.R.), Pacific Northwest National Laboratory, Richland, Washington
Drug Metab Dispos. 2016 Jul;44(7):984-91. doi: 10.1124/dmd.115.068593. Epub 2016 Apr 15.
Cytochrome P450s are oxidative metabolic enzymes that play critical roles in the biotransformation of endogenous compounds and xenobiotics. The expression and activity of P450 enzymes varies considerably throughout human development; the deficit in our understanding of these dynamics limits our ability to predict environmental and pharmaceutical exposure effects. In an effort to develop a more comprehensive understanding of the ontogeny of P450 enzymes, we employed a multi-omic characterization of P450 transcript expression, protein abundance, and functional activity. Modified mechanism-based inhibitors of P450s were used as chemical probes for isolating active P450 proteoforms in human hepatic microsomes with developmental stages ranging from early gestation to late adult. High-resolution liquid chromatography-mass spectrometry was used to identify and quantify probe-labeled P450s, allowing for a functional profile of P450 ontogeny. Total protein abundance profiles and P450 rRNA was also measured, and our results reveal life-stage-dependent variability in P450 expression, abundance, and activity throughout human development and frequent discordant relationships between expression and activity. We have significantly expanded the knowledge of P450 ontogeny, particularly at the level of individual P450 activity. We anticipate that these results will be useful for enabling predictive therapeutic dosing, and for avoiding potentially adverse and harmful reactions during maturation from both therapeutic drugs and environmental xenobiotics.
细胞色素P450是氧化代谢酶,在内源性化合物和外源性物质的生物转化中起关键作用。P450酶的表达和活性在人类整个发育过程中差异很大;我们对这些动态变化的理解不足限制了我们预测环境和药物暴露影响的能力。为了更全面地了解P450酶的个体发生,我们采用了多组学方法对P450转录本表达、蛋白质丰度和功能活性进行表征。使用基于机制的P450修饰抑制剂作为化学探针,以分离处于从妊娠早期到成年晚期不同发育阶段的人肝微粒体中的活性P450蛋白变体。采用高分辨率液相色谱-质谱法鉴定和定量探针标记的P450,从而获得P450个体发生的功能概况。还测量了总蛋白丰度概况和P450 rRNA,我们的结果揭示了在人类整个发育过程中P450表达、丰度和活性的生命阶段依赖性变异性,以及表达与活性之间频繁的不一致关系。我们显著扩展了对P450个体发生的认识,特别是在个体P450活性水平上。我们预计这些结果将有助于实现预测性治疗给药,并避免在从治疗药物和环境外源性物质成熟过程中可能出现的不良和有害反应。